| | California Central District Drug Threat Assessment |
| | 2,05 | | MB |
| | 46 | | stron |
| | 5689 | | ID | National Drug Intelligence Center |
| | 2001 | | rok |
| | Table of Contents |
| | Executive Summary iii |
| | Overview .1 |
| | Cocaine.4 |
| | Abuse . .4 |
| | Availability .5 |
| | Violence . .6 |
| | Production . .7 |
| | Transportation .7 |
| | Distribution .8 |
| | Methamphetamine . .11 |
| | Abuse .12 |
| | Availability . .12 |
| | Violence .13 |
| | Production .13 |
| | Transportation . .16 |
| | Distribution . .16 |
| | Heroin.17 |
| | Abuse .18 |
| | Availability . .18 |
| | Violence .19 |
| | Production .19 |
| | Transportation . .20 |
| | Distribution . .21 |
| | Marijuana .22 |
| | Abuse .23 |
| | Availability . .23 |
| | Violence .24 |
| | Production .24 |
| | Transportation . .25 |
| | Distribution . .26 |
| | Other Dangerous Drugs . .27 |
| | MDMA . .27 |
| | GHB . .29 |
| | LSD . .29 |
| | PCP . .30 |
| | Rohypnol . .30 |
| | Ketamine . .31 |
| | Outlook .32 |
| | Sources . 33 |